Drugs / broccoli sprout extract

Trials 6

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT01753908 May 2013 → Jul 2018 breast lobular carcinoma, ductal breast carcinoma in situ, estrogen-receptor negative breast cancer, estrogen-receptor positive breast cancer +1 Roswell Park Cancer Institute Completed No outcome recorded
Phase 11 trial
Phase 1 NCT02592954 Sep 2015 → Dec 2016 epidermolysis bullosa simplex, pachyonychia congenita Johns Hopkins University Completed No outcome recorded
Phase 21 trial · 1 missed
Phase 2 NCT00982319 Apr 2009 → Nov 2013 female breast carcinoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Completed Missed primary
Phase not applicable3 trials · 1 met primary
— NCT01108003 Apr 2010 → Sep 2014 non-invasive bladder urothelial carcinoma Roswell Park Cancer Institute Terminated No outcome recorded Stop: Enrollment
— NCT00994604 Oct 2009 → Aug 2015 asthma, chronic obstructive pulmonary disease Johns Hopkins University Completed No outcome recorded
— NCT00882115 Jul 2009 → Dec 2011 allergic respiratory disease University of California, Los Angeles Completed Met primary

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Broccoli Sprout Extract ClinicalTrials.gov intervention name — accepted as the source's own label NCT01753908 ↗
5

NCT00994604 ↗

NCT02592954 ↗

NCT00882115 ↗

NCT01108003 ↗

NCT00982319 ↗

Known as BSE “a standardized broccoli sprout extract (BSE), which contains a reproducible amount of the sulforaphane (SFN) precursor” PMID 24287881 ↗ Jan 2014
2

“Each participant will receive 7ml of broccoli sprout extract (BSE) in jojoba oil, containing 3500nmol of sulforaphane” NCT02592954 ↗

“broccoli sprout extract (BSE), rich in sulforaphane, improves airflow measures in asthmatics.” NCT00994604 ↗

Known as ITC-BSE “I. To determine whether isothiocyanate-rich broccoli sprout extract (ITC-BSE) modifies biomarkers in breast tumor cells.” NCT01753908 ↗
Action Activate “induces NAD(P)H dehydrogenase (quinone) 1 (NQO1) expression” NCT01753908 ↗
Route Oral “BSE will be ingested by drinking a liquid formula” NCT00882115 ↗
Target NQO1 “induces NAD(P)H dehydrogenase (quinone) 1 (NQO1) expression” NCT01753908 ↗